glp-1 microbiome A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism: Cell Metabolism Did you know the "super-responders"
Description
Diarrhea affected 13-16% of patients with diabetes and up to 30% in obesity trials, while vomiting occurred in 5-9% of those treated with tirzepatide for diabetes and up to 24% in obesity studies
[DOI] [PubMed] [Google Scholar] 211.Morgan-Bathke M., Raynor H.A., Baxter S.D., Halliday T.M., Lynch A., Malik N., Garay J.L., Rozga M
TrimBody M.D
initially spearheaded this research
P., Levy M
With its remarkable safety profile and noteworthy percentages of weight reduction, it undeniably generates considerable enthusiasm within the medical community
